Purpose: To develop an in-vivo imaging method for the measurement of dorsal-root-ganglia-(DRG) perfusion, to establish its normal values in patients without known peripheral nerve disorders or radicular pain syndromes and to determine the physiological spatial perfusion pattern within the DRG. Methods: This prospective study was approved by the institutional ethics committee and written informed consent was obtained from all participants. 46 (24 female, 22 male, mean age 46.0 ± 15.2 years) subjects without known peripheral neuropathies or pain syndromes were examined by a 3 Tesla MRI scanner (Magnetom VERIO or TRIO, Siemens AG, Erlangen, Germany) with a VIBE (Volume-Interpolated-Breathhold-Examination) dynamic-contrast-enhanced (DCE) T1-w-sequence (TR/TE 3.3/1.11 ms; 24 slices; voxel resolution 1.3 × 1.3 × 3.0 mm 3 ) covered the pelvis from the upper plate of the 5th lumbar vertebra to the 2nd sacral vertebra. Transfer-constant (K trans ) and interstitial-volume-fraction (interstitial-leakage-fraction, V e ) were modeled for the DRG and spinal nerve by applying the Tofts-model. Statistical analyses included pairwise comparisons of L5/S1 DRG vs. spinal nerve. Furthermore, distinct physiological zones within the S1 DRG were compared (cell body rich area (CBRA) vs. nerve fiber rich area (NFRA)). Results: DRG showed a significantly increased permeability compared to spinal nerve (K trans 3.8 ± 1.5 10 /min, p-value: b0.001 and V e 40.9 ± 21.3% vs. 15.1 ± 11.7%, p-value: b 0.001). Conclusion: Non-invasive and in-vivo measurement of human DRG perfusion by MRI is a feasible technique. DRG show substantially higher permeability and interstitial leakage than spinal nerves. Even distinct physiological perfusion patterns for different microstructural compartments could be observed within the DRG. The technique may become particularly useful for future research on the poorly understood human sensory neuropathies and pain syndromes.
Introduction
The dorsal-root-ganglia (DRG) represent dense accumulations of nerve cell bodies of the primary sensory neurons and are located pairwise in, or closely adjacent to the intervertebral foramina along the spine. The prime electrophysiological function of the DRG is to receive the bulk afferent sensory input from the PNS and relay it to the CNS.
A nerve fiber rich area (NFRA), which is located more centrally, contains the incoming and outgoing nerve fibers (Fig. 1) , whereas the peripheral regions of the DRG are denominated cell body rich area (CBRA) for containing the densely accumulated cell bodies of the pseudounipolar, sensory neurons, which are embedded in a dense capillary network (Jimenez-Andrade et al., 2008) . Blood supply to the DRG is provided by the spinal branch of the dorsal trunk of the segmental arteries. After penetrating the ganglionic capsule, the arteries give rise to a subcapsular capillary plexus prior to penetrating into the deeper part of the ganglion and branching into intraganglionic blood vessels (Kobayashi et al., 2010) . The regulation of blood flow to the DRG is achieved by muscular sphincters at strategic locations along the arteriole trunks and their branching points, to adjust flow to varying functional and metabolic demand (Kobayashi et al., 2010) .
While the peripheral nervous system (PNS) generally has a tight blood-nerve interface similar to the blood-brain-barrier (Weerasuriya & Mizisin, 2011) , the DRG are intensely vascularized organs with high permeability between blood and nervous tissue (Jimenez-Andrade et al., 2008; Hirakawa et al., 2004; Jacobs, 1978; Anzil et al., 1976; Jacobs et al., 1976) . This exception to the otherwise restricted permeability of the PNS is potentially of high clinical relevance, because of the vulnerability to low and high molecular weight neurotoxic substances (Cavanagh, 1973; Cho, 1977; London & Albers, 2007; Le Quesne & McLeod, 1977; Viaene et al., 1999; Ikeda et al., 1973) as well as to toxic metabolites in drug-or metabolic-induced neuropathies (Lee & Swain, 2006; Quasthoff & Hartung, 2002; Mielke et al., 2006; Pignata et al., 2006; Pardo et al., 2001; Pettersen et al., 2006; McArthur et al., 2005; Berger et al., 1993; Keswani et al., 2002; Nicholas et al., 2007a; Nicholas et al., 2007b; Rahman et al., 2016) .
In the CNS it is firmly established that an increased neural activity is accompanied by an elevated, measurable oxygenation, blood volume and flow (Logothetis & Pfeuffer, 2004) . Therefore it is likely, that particularly the increased activity of DRG neurons, which may especially occur in pathological conditions of increased excitability and activation (Xiao et al., 2016; Hogan, 2007; Sapunar et al., 2005; Zhang et al., 2004) , also leads to increasing demands in DRG perfusion. Furthermore, the DRG plays an increasingly important role in the treatment of pain syndromes and neuropathic pain as a target of electrical neurostimulation (Pei et al., 2015; Forget et al., 2015; Eldabe et al., 2015; Van Buyten et al., 2015; Liem et al., 2013; Koopmeiners et al., 2013) .
Current knowledge about DRG perfusion is limited and comes from experimental animal studies only (Jimenez-Andrade et al., 2008; Kobayashi et al., 2010) . Despite the potential physiological and clinical relevance, to the best of our knowledge, in-vivo measurements in humans have not been reported so far.
Dynamic-contrast-enhanced (DCE) methods of MRI perfusion have long been utilized for the clinical and functional imaging investigation of the CNS. These methods have only recently been tested for the PNS targeting the trunks of peripheral nerve at the proximal extremities (Baumer et al., 2014) . DCE MRI can be used for the calculation of perfusion parameters such as the interstitial leakage of contrast agent (V e ) and blood-tissue permeability (K trans ), providing functional in-vivo information that is otherwise not available in humans (Cuenod & Balvay, 2013; Sourbron, 2010) . In this study we developed a DCE MRI method dedicated to the quantitative measurement of DRG perfusion and applied this method in patients without peripheral neuropathies or pain syndromes.
Patients and methods

Clinical and demographic patient data
This study was approved by the institutional ethics board (S398-2012) and written informed consent was obtained from all patients. Overall, we included 46 patients (24 female, 22 male, age 46.0 ± 15.2 years) for whom a contrast-enhanced examination of the spine was indicated for reasons not pertaining to any peripheral nervous system disorder (spinal MRI to rule out metastases, spinal tumors, multiple sclerosis, spinal hemorrhage or fractures of a lumbar vertebra). Patients with symptoms suggestive of any peripheral neuropathy or radiculopathy were explicitly excluded from the study.
Imaging
Examinations were conducted at a 3 Tesla MRI scanner (Magnetom VERIO or TRIO, Siemens AG, Erlangen, Germany) between 7/2015 and 12/2015. The position of the imaging slab was chosen so that its upper edge was aligned in parallel with the upper plate of the 5th lumbar vertebra. Before contrast agent administration, T1-weighted volumetricinterpolated-breathhold-examination (VIBE) sequences with 5°, 8°, 11°, 14°and 17°flip angle were acquired. Then, a T1-weighted, dynamic-contrast-enhanced (DCE) VIBE sequence was acquired with the following sequence parameters: TR/TE 3.3/1.11 ms; flip angle 15°; 24 slices; resolution 1.3 × 1.3 × 3.0 mm 3 . The contrast agent (Dotarem, Guerbet, France) was administered intravenously at the beginning of the third frame of the sequence at the standard concentration of 0.1 mmol/kg with a flow rate of 3.5 ml/s by automated injection. A total of 24 frames were recorded with a rate of 7.46 s/frame. A 15-channel receive/transmit spine coil and an 8-channel receive body flex coil (Siemens) were used.
Quantitative image analysis
Quantitative image analysis was performed using the commercially available software plug-in IB DCE 1.2 (Imaging Biometrics, Elm Grove, USA) to Osirix (Pixmeo, Bernex, Switzerland). Image masks were obtained by manual segmentation around the contour of the L5 and S1 DRG, which were reliably visible in the anatomical, T1-weighted nonenhanced image (Fig. 2) . As internal control, the 5th lumbar spinal nerve on the right side at a presacral localization was likewise measured. This nerve was chosen because of its anatomical positioning in the same imaging slab as the L5 and S1 DRG. Additional regions-ofinterests (ROIs) were placed in the common iliac artery to obtain time-signal curves needed to define the arterial input function (AIF) and to detect the time point of bolus arrival in the lumbar region. Since it is not possible to differentiate the central (NFRA) and peripheral (CBRA) zone on conventional MR images, further masks were obtained by defining these areas on the K trans /V e maps which were rendered voxel-wise as described below.
Voxel-wise modeling of K trans and V e
The Tofts model is the most common pharmacokinetic model assuming a tissue compartment in addition to a vascular compartment. Given the Gadolinium (Gd) concentration as a function of time, it models how the contrast agent distributes in the body and how this depends on characteristics of DRG and spinal nerve perfusion. K trans (expressed in min ) is the most important and significant tissue dependent parameter in Tofts. It assesses either plasma flow in flowlimited scenarios or tissue permeability in permeability-limited scenarios for the uptake. In mixed scenarios it indicates a combination of the flow and permeability properties of the tissue.
Since the applied contrast agent Dotarem is of small molecular size (559 Da, Gd-DOTA), its leakage from the capillaries into the extracellular, extravascular space (EES) is diffusive and hence reversible; it is therefore proportional to the difference in concentrations between the two compartments and K trans is the constant of this proportionality.
Furthermore the modeling reveals the interstitial blood volume fraction V e (interstitial leakage fraction, expressed in %). Preliminary evaluations of the time-dependent signal increase after contrast administration showed a relatively fast influx of contrast agent into the DRG tissue. This observation suggested use of the Tofts model for modeling a concentration time curve to the measured data.
We calculated these parameters for the ROI within the DRG L5 and S1 and the spinal nerve L5.
Statistical analysis
Data visualization and statistical analyses were performed using Microsoft Excel. Mean values were calculated for K trans and V e in each subject for DRG L5 and S1 as well as spinal nerve L5. Bar charts for K trans and V e were charted in Microsoft Excel. CBRA and NFRA values of the S1 DRG were charted. Mean values were tested for statistical significance using a Student's t-Test, with a two-sided alpha level for significance of p-value: b0.05. Pearson correlation analysis was performed for age vs. K trans /V e .
Results
Perfusion parameter maps of the DRG and spinal nerves were generated (Fig. 3) and quantitatively assessed for a total of 46 participants (Figs. 4, 5) .
DRG K trans values were significantly increased compared to spinal nerve L5 (K trans = 3.8 ± 1.5 10 − 3 /min vs. 1.6 ± 0.9 10 − 3 /min, p- value: b 0.001). Likewise, V e was significantly higher in the DRG compared to the spinal nerve L5 (V e = 38.1 ± 19.2% vs. 17.3 ± 9.9%, pvalue: b 0.001, Fig. 4 /min, p-value: b 0.05) whereas interstitial leakage fraction showed no statistically significant differences (V e female 40.1 ± 14,1% vs. male 34.5 ± 17.4%, p-value: 0.24).
Since peripheral nerves are known to show age-related degenerative changes, correlation analyses between perfusion parameters and age were performed. No significant correlations between age and K trans or V e were observed.
Quantitative readout parameters (K trans and V e ) of the peripheral zone (CBRA) were compared to the values at the central zone (NFRA) of the S1 DRG (Fig. 5) . In this comparison, the DRG showed a distinct spatial pattern of distribution of K trans and V e (Fig. 5) . Theses parameters were significantly higher in the peripheral zone than in the central zone (K trans = 4.4 ± 1.8 10 /min, p-value: b 0.001 and V e = 40.9 ± 21.3% vs. 15.1 ± 11.7%, p-value: b 0.001).
Discussion
In this study we show that DCE MRI can be used to measure human DRG perfusion in-vivo by parameters of blood-tissue permeability (K trans ) and interstitial leakage fraction (V e ). To our knowledge this is the first in-vivo investigation of physiologic and metabolic human DRG function indicated by quantitative parameters of DRG perfusion and permeability. The assessed perfusion parameters of blood-tissue permeability (K trans ) and leakage of contrast agent into the interstitial space (V e ) were significantly increased in the DRG compared to the spinal nerve. Additionally, perfusion parameters in the peripheral zone of the DRG, containing cell bodies of the primary sensory neurons (CBRA), were significantly increased compared to the central NFRA, containing the incoming and outgoing nerve axons. Interestingly, the perfusion parameters of the spinal nerve were roughly similar compared to the central NFRA in DRG, which may be related to microstructural similarities and adjacency between these two segments of the PNS (spinal nerve trunk continuing partly as the fibers entering the DRG). Altogether, these observations are consistent with former invasive animal studies, using autoradiographical measurements and immunohistochemical methods, that revealed a three-fold increase of blood flow within the DRG compared to peripheral nerve (Sasaki et al., 1997) as well as a seven-fold blood-vessel-density in the CBRA compared to the NFRA (Jimenez- Andrade et al., 2008) .
Microvascular approaches in animals using light, immunofocal and electron-microscopy after intravenous injection of tracers have also previously shown that the blood vessels of the CBRA have large fenestrations and a relative lack of tight junction proteins compared to the peripheral nerve (Jacobs, 1978; Anzil et al., 1976; Jacobs et al., 1976) , allowing large molecules to leak out of the CBRA supporting microvasculature while remaining intravascularly within the NFRA and the peripheral nerves (Hirakawa et al., 2004; Jacobs et al., 1976; Arvidson, 1979; Olsson, 1968) .
The blood-nerve-barrier in peripheral nerves forms a tight and highly regulated interface similar to the blood-brain-barrier (Weerasuriya & Mizisin, 2011). The specific purpose of the particular leaky structure of the DRG blood tissue border and the physiologically elevated leakage of its microvascular endothelium (Hirakawa et al., 2004 ) is likely to satisfy the high metabolic demand of sensory cell bodies including those that need to support the longest axons innervating the most distal extremity regions (Devor, 1999 ). An increased perfusion coupled with dense vascularization, the lack of tight junction proteins and the presence of large, endothelial fenestrations may synergistically contribute to an increased vulnerability of primary sensory neurons of the DRG to neurotoxic agents. Drug induced neuropathic pain is one of the major side effects of chemotherapy for example in cancer or HIV-treatment (Pettersen et al., 2006; Fallon, 2013) . It is characterized by numbness, tingling, burning sensation and cold allodynia (Pain Suppl., 1986) . The risk of neuropathy is proportional to the dose and duration of drug administration (Lee & Swain, 2006; Seidman et al., 2008) . While the cell bodies of alpha-motoneurons are housed within the tight blood-brain-barrier of the CNS, the sensory neuron bodies of the DRG are exposed to toxic substances circulating in the blood. This microstructural feature, specific for the DRG, likely explains why anti-neoplastic and anti-HIV agents preferably induce a peripheral sensory polyneuropathy frequently characterized by neuropathic pain. Interestingly, the in-vivo morphometric measurement of the DRG in oxaliplatin induced chemotoxic sensory and painful distally symmetric polyneuropathy revealed clear signs of structural degeneration during the course of disease (Bäumer et al., 2015) . This observation further points towards a central and primary role of the DRG in the pathogenesis particularly of toxic metabolically induced painful polyneuropathies.
Dose escalation of chemotherapeutic agents (e.g. cisplatin) is frequently necessary to prolong survival in a variety of oncologic conditions (Mielke et al., 2006; Aghajanian et al., 1998; Pasini et al., 2002; Cocconi et al., 1999) . In contrast to neuropathy, other side effects such as drug-induced hypersensitivity or neutropenia represent treatable conditions (e.g. by treatment with antihistamines, steroids or granulocyte colony-stimulating factor (Einzig et al., 1998) ). However, the symptoms and the electrophysiological and structural alterations of chemotherapy induced peripheral neuropathy unfortunately still represent complications which are currently untreatable, eventually dose limiting and may lead to discontinuation of chemotherapy (Lee & Swain, 2006; Quasthoff & Hartung, 2002; Mielke et al., 2006; Pignata et al., 2006) .
In our study female gender was associated with a significantly increased vascular permeability within the DRG. Consistent with this observation, various clinical studies have reported that females may be more sensitive to chronic and neuropathic pain than males (Ruau et al., 2012; Hurley & Adams, 2008; Fillingim et al., 2009) . Gender differences in chemotherapy induced neuropathic pain have only been investigated in animal studies so far, showing contradictory results. While there was no gender difference in cisplatin induced cold and mechanical allodynia, female mice showed an increased sensitivity against cold allodynia, but not mechanical allodynia in paclitaxel induced polyneuropathy (Naji-Esfahani et al., 2016) . In contrast, another animal study observed no gender difference in paclitaxel induced neuropathic pain (Hwang et al., 2012) .
The regulation of blood flow into and within the DRG is achieved by muscular sphincters at strategical locations along the arteriole trunks and their branching points, to adjust flow to varying functional and metabolic demand (Kobayashi et al., 2010) . It is conceivable that DRG not only adapt vascular supply and blood flow or permeability to functional variability dependent on short-term activity but also to long-term changes in neuronal activity or excitability which particularly may occur in sensory neuropathies and neuropathic pain syndromes (Xiao et al., 2016; Hogan, 2007; Sapunar et al., 2005; Zhang et al., 2004) . DCE MRI could potentially identify such alterations in DRG perfusion. The potential clinical relevance of measuring this is indicated by findings that increased neuronal excitability may cause or aggravate the symptoms of human sensory neuropathies including neuropathic pain (Obata & Noguchi, 2008; Zhao et al., 2015; Malet & Brumovsky, 2015) , oxaliplatin induced toxic sensory neuropathy (Zhao et al., 2012) , lumbar disc herniation (Yan et al., 2015) , or inflammatory pain (Malet & Brumovsky, 2015) .
In contrast, metabolic dysfunction also plays a crucial role in the pathogenesis of diverse pain syndromes. In-vitro animal studies using electrostimulation demonstrated that DRG are highly sensitive to hypoxia induced by mechanical compression, causing abnormal sensations and pain in radiculopathy (Sugawara et al., 1996) . The painful symptoms of diabetic neuropathy, which often dominate during the early stages of this most prevalent human neuropathy, likely result from metabolic aberrations leading to biochemical, structural and functional changes in the DRG (Sima & Sugimoto, 1999; Tavee & Zhou, 2009) . Animal studies suggest that tissue ischemia and lower ambient oxygen tension in the DRG due to hyperglycemia may lead to aberrant metabolic functions and sensory symptoms (Rahman et al., 2016) .
Given this wide spectrum of potential relevance, it can be anticipated that in-vivo methods of measuring aspects of human DRG perfusion such as the one presented here, will find application in the investigation of the time course and localization of highly prevalent but poorly understood PNS disorders such as drug-or metabolic-induced peripheral sensory neuropathies and neuropathic pain syndromes. Beyond these fields, changes in DRG perfusion most likely play an important role in low back pain and sciatica in patients with disc herniation and spinal canal stenosis.
Our study has several limitations. First, it is a limitation of our study and of any DCE MRI perfusion technique that the absolute values of perfusion parameters as reported here needed to be modeled. We chose the Tofts model for this purpose because it is valid particularly for parameter estimation in tissues with high vascular permeability. A limitation of the Tofts model is the fact that plasma flow and tissue permeability cannot be estimated separately. Changes in K trans can be attributed to changes in plasma flow or tissue permeability only if the flow regime meets certain presuppositions. Second, sequence parameters in DCE-MRI are a compromise between coverage, temporal, and spatial resolution. Small variations in the arterial input function (AIF) due to a relatively low temporal resolution does not affect the intraindividual ratio of perfusion parameters between different levels (S1/ L5) or sides (right/left), but it results in some inter-individual variation of the absolute perfusion parameters. Third, the normal values presented here may depend to some extent on the sequence parameters chosen, and researchers adopting the technique will have to confirm their own control values on their scanner system. And fourth, since there is no possibility to distinguish the central (NFRA) and peripheral (CBRA) zones in the anatomical image, additional ROIs where drawn by defining these areas in the acquired K trans /V e maps.
Conclusion
The non-invasive and in-vivo measurement of human DRG perfusion is feasible by MRI and shows a substantially higher permeability and interstitial leakage in the DRG than spinal nerves. Even distinct physiological perfusion patterns could be observed for different microstructural compartments within the DRG. These advances may become particularly useful for future studies on the poorly understood human sensory neuropathies and pain syndromes.
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